The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomas.
 
Jennifer Leigh Clarke
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
 
Annette M Molinaro
No Relationships to Disclose
 
Ashley A DeSilva
No Relationships to Disclose
 
Jane E Rabbitt
No Relationships to Disclose
 
Daryl C. Drummond
Employment - Merrimack
Leadership - Merrimack
Stock and Other Ownership Interests - Merrimack
Research Funding - Merrimack
Patents, Royalties, Other Intellectual Property - patents and royalties related to the development of nanotherapeutics
 
Susan Marina Chang
Research Funding - Novartis (Inst); Quest diagnostics (Inst); Schering-Plough Research Institute (Inst)
 
Nicholas A. Butowski
Honoraria - Genentech
Consulting or Advisory Role - Genentech/Roche
Research Funding - Abbvie; Bristol-Myers Squibb; Lilly; Merrimack; NewGen Therapeutics; Novartis; Proximagen; Stemline Therapeutics
 
Michael Prados
Research Funding - Genentech (Inst); Novartis (Inst); Pfizer (Inst)